RTTNews | Jan 10, 2022 06:24AM EST

06:23 Monday, January 10, 2022 (RTTNews) - Reviva Pharma Gets FDA Clearance To Proceed With Initiation Of Pivotal Phase 3 Trial Of Brilaroxazine For Schizophrenia

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved